Your browser doesn't support javascript.
loading
Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients.
Fadel, Hewida H; Ahmed, Mohammad Abd El-Rahman; Gharbeya, Kareem Mahamoud; Mohamed, Mohammed Ahmed Khamis; Roushdy, Mohamed N; Almiry, Reda.
Affiliation
  • Fadel HH; Department of Medical Laboratory Technology, Faculty of Allied Medical Science, Pharos University, Alexandria, Egypt.
  • Ahmed MAE; Department of Clinical Pathology, Military Medical Academy, Alexandria Armed Forces Hospital, Egypt.
  • Gharbeya KM; Critical Care Consultant at Alexandria Armed Forces Hospital, Egypt.
  • Mohamed MAK; Pulmonary Consultant at Alexandria Armed Forces Hospital, Egypt.
  • Roushdy MN; Department of Medical Microbiology and Clinical Immunology, Military Medical Academy, Alexandria Armed Forces Hospital, Egypt.
  • Almiry R; Molecular and Diagnostic Microbiology, Molecular Microbiologist Consultant at Alex Armed Forces Hospital, Egypt.
Dis Markers ; 2022: 6780710, 2022.
Article in En | MEDLINE | ID: mdl-35655915

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Repressor Proteins / Basic Helix-Loop-Helix Transcription Factors / COVID-19 Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Dis Markers Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Repressor Proteins / Basic Helix-Loop-Helix Transcription Factors / COVID-19 Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Dis Markers Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: Country of publication: